NOVAVAX INC - COM (NVAX)

CUSIP: 670002104

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM
Total 13F shares
157,825,620
Share change
-59,243
Total reported value
$290,398,833
Put/Call ratio
33%
Price per share
$1.84
Number of holders
162
Value change
-$420,918
Number of buys
72
Number of sells
56

Quarterly Holders Quick Answers

What is CUSIP 670002104?
CUSIP 670002104 identifies NVAX - NOVAVAX INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NOVAVAX INC - COM (NVAX) as of Q4 2018

As of 31 Dec 2018, NOVAVAX INC - COM (NVAX) was held by 162 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 157,825,620 shares. The largest 10 holders included BlackRock Inc., Vanguard Group Inc, STATE STREET CORP, BB BIOTECH AG, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, FRANKLIN RESOURCES INC, NORTHERN TRUST CORP, and MORGAN STANLEY. This page lists 162 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.